1. Home
  2. NTRA vs ALL Comparison

NTRA vs ALL Comparison

Compare NTRA & ALL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$272.94

Market Cap

56.7B

Sector

Health Care

ML Signal

N/A

Logo Allstate Corporation (The)

ALL

Allstate Corporation (The)

N/A

Current Price

$267.01

Market Cap

63.5B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
NTRA
ALL
Founded
2003
1931
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
56.7B
63.5B
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
NTRA
ALL
Price
$272.94
$267.01
Analyst Decision
Strong Buy
Hold
Analyst Count
23
25
Target Price
★ $412.36
$277.91
AVG Volume (30 Days)
★ 2.0M
1.4M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
★ 1.62%
EPS Growth
★ 0.65
N/A
EPS
N/A
★ 29.79
Revenue
$210,939,000.00
★ $67,685,000,000.00
Revenue This Year
$30.72
$3.85
Revenue Next Year
$21.67
$3.48
P/E Ratio
★ N/A
$8.95
Revenue Growth
N/A
★ N/A
52 Week Low
$181.00
$191.13
52 Week High
$437.41
$281.11

Technical Indicators

Market Signals
Indicator
NTRA
ALL
Relative Strength Index (RSI) 24.66 61.10
Support Level $254.83 $252.95
Resistance Level $288.04 $277.91
Average True Range (ATR) 19.03 6.15
MACD -7.70 -0.05
Stochastic Oscillator 1.47 56.78

Price Performance

Historical Comparison
NTRA
ALL

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About ALL Allstate Corporation (The)

Allstate is one of the largest US property-casualty insurers in the US. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 6,000 exclusive agents.

Share on Social Networks: